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Abstract
Background: Health checks identify (risk factors for) disease in people without symptoms. They may be offered by
the government through population screenings and by other providers to individual users as ‘personal health checks’.
Health check providers’ perspective of ‘good’ health checks may further the debate on the ethical evaluation and possible
regulation of these personal health checks.
Methods: In 2015, we interviewed twenty Dutch health check providers on criteria for ‘good’ health checks, and the role
these criteria play in their practices.
Results: Providers unanimously formulate a number of minimal criteria: Checks must focus on (risk factors for) treatable/
preventable disease; Tests must be reliable and clinically valid; Participation must be informed and voluntary; Checks
should provide more benefits than harms; Governmental screenings should be cost-effective. Aspirational criteria
mentioned were: Follow-up care should be provided; Providers should be skilled and experienced professionals
that put the benefit of (potential) users first; Providers should take time and attention. Some criteria were contested:
People should be free to test on any (risk factor for) disease; Health checks should only be performed in people at high
risk for disease that are likely to implement health advice; Follow up care of privately funded tests should not drain on
collective resources.
Providers do not always fulfil their own criteria. Their reasons reveal conflicts between criteria, conflicts between criteria
and other ethical values, and point to components in the (Dutch) organisation of health care that hinder an ethical
provision of health checks. Moreover, providers consider informed consent a criterion that is hard to establish in
practice.
Conclusions: According to providers, personal health checks should meet the same criteria as population screenings,
with the exception of cost-effectiveness. Providers do not always fulfil their own criteria. Results indicate that in thinking
about the ethics of health checks potential conflicts between criteria and underlying values should be explicated,
guidance in weighing of criteria should be provided and the larger context should be taken into account:
other actors than providers need to take up responsibility, and ideally benefits and harms of health checks
should be weighed against other measures targeting (risk factors for) disease.
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Background
Population screening and personal health checks:
Benefits and harms
Health checks identify (risk factors for) disease.1 Unlike
diagnostic tests, they are offered to or requested by
people without specific symptoms. [1] Health checks can
also be referred to as preventive or presymptomatic
tests, medical screening or preventive medical examina-
tions. For ease of reading, ‘health check’, ‘check’ and ‘test’
are used interchangeably throughout this paper.
Health checks may be offered by different providers. If
provided by the government we refer to them as popula-
tion screening programs. In the Netherlands, there are
population screening programs for breast cancer, bowel
cancer and cervical cancer. In the United Kingdom,
there is also screening for risk factors for cardiovascular
disease (CVD). Typically, people in the target group re-
ceive an invitation to participate. Most population
screening programs are provided free of charge.
Health checks may also be provided by other parties,
and this is increasingly the case. In the Netherlands, phys-
iotherapists, pharmacies, General Practitioners (GPs),
gyms, Non Governmental Organisations such as the Heart
Foundation, specialized medical centres and companies
offer checks on a wide variety of (risk factors for) disease,
including cancer and CVD. Examples include the total
body scan, tests for prostate specific antigen (PSA) and
genetic tests. Because these tests are not offered to (sub)-
populations but to individuals – through advertisements
for example – we will refer to them as ‘personal health
checks’ throughout this paper. Note that the distinction
between population screenings and personal health checks
depends on whether the offer is directed at a population
or at an individual. The same test can be used in popula-
tion screening programs and as personal health check.
Population screening programs and personal health
checks can provide insight into one’s health status.
When risk factors or latent disease are uncovered, pre-
ventive action may improve health. However, not all
conditions are treatable. In addition, false positive or
negative results may lead to unnecessary treatment or
unjustified reassurance with potentially negative conse-
quences for health. If the course of disease is hard to
predict even accurate diagnosis may lead to overtreat-
ment. Some tests carry risks in themselves, such as inva-
sive tests or tests using radiation. [2] Moreover, health
check offers may indirectly result in decreased health
solidarity and unfairly distributed health outcomes. [3]
The weighing of benefits and harms for individuals and
society requires ethical evaluation. [1–3]
Ethicists usually do not distinguish between popula-
tion screening and personal health checks when it comes
to benefits and harms and the weighing thereof. [2, 4–6]
This is different however in policy and regulation.
Evaluation of population screening and personal health
checks in policy, law and regulation
Traditionally, policymakers and public health profes-
sionals use ethical criteria for responsible screening, de-
rived from the Wilson and Jungner criteria, to evaluate
whether or not population-screening programs should
be offered. [7–10] Criteria for responsible population
screening state that the screening should have clinical
utility1, the benefits for the participants must outweigh
the drawbacks, the test method must be both analytically
valid2 and clinically valid,3 participation must be volun-
tary and based on reliable information, the offer and per-
formance of screening should be in accordance with
patient- and consumer rights, and the screening must be
responsible in terms of the use it makes of public and
collective health service resources. [summary derived
from 5] There is discussion about whether or not spe-
cific population screening programs meet these criteria,
but the criteria themselves are relatively uncontested. [9]
In the Netherlands and Belgium there is also legal evalu-
ation of population screening. [11, 12] In the
Netherlands this concerns a mandatory permit for
screening that uses ionizing radiation, aims to detect
cancer or diseases for which there is no treatment or
prevention. Grounds to refuse a permit are (i) the
screening test is scientifically unsound; (ii) the screening
does not conform the legal rules for medical treatment;
(iii) the expected benefit of the screening does not out-
weigh the risks for the participants. To determine the
risk–benefit ratio for participants, the Wilson and
Jungner criteria are used. [9]
As stated, most ethicists think that the Wilson and
Jungner criteria are also applicable to personal health
checks. [2, 4–6] However, policymakers disagree on the
question whether personal health checks – like popula-
tion screening – should be regulated and if so, which
criteria should be used. For the ethical evaluation of per-
sonal health checks, several policy proposals have been
made.4 On a European level quality criteria have been
developed [13], in the United Kingdom, principles for
direct to consumer genetic tests have been designed that
may be applied to all personal health checks across all
jurisdictions [14], the Health Council of the Netherlands
(HCN) has written on the ethical evaluation of personal
health checks [1] and the Royal Dutch Medical Associ-
ation has published a guideline. [15] The latter has been
withdrawn but was in operation during the time of
this study. In the Netherlands – as in other European
countries – there is limited regulation of personal
health checks. [11] Several parties have indicated that
more regulation, or more compliance with and over-
sight of existing laws and regulations, is necessary to
protect citizens against harmful effects of personal
health checks. [1, 12]
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As yet, there is no consensus on the criteria for ‘good’
personal health checks. The criteria in existing policy
proposals vary, but are less stringent than criteria for re-
sponsible population screening: For example, none of
the published guidelines mentions clinical utility and
cost-effectiveness. [1, 13–15]. Clinical validity is only
considered a criterion by the HCN [1], analytic validity
by the HCN [1] and HGC. [14] Just as criteria for re-
sponsible populations screening, criteria for personal
health checks mention informed consent. [1, 13–15] The
question why criteria for personal health checks divert
from criteria for responsible population screening, is an-
swered by the Health Council of the Netherlands stating
that ‘health gains are not necessarily a precondition for
the individual. For the individual, the results obtained
may be of use purely as information or they may be
valuable in terms of reassurance. Also, cost-effectiveness
is not a prime concern for the individual.’ [1]
Towards a new ethical framework for personal health
checks
There is currently much public, policy and political de-
bate in the Netherlands on the regulation of health
checks. [16–19] This study aims to contribute to an eth-
ical framework for responsible offers and use of personal
health checks. We aim to formulate context-sensitive yet
general criteria that – like the Wilson and Jungner cri-
teria – may be applied to all sorts of tests. Criteria may
also help providers in evaluating and adjusting their
health check offers.
In order to develop ethical criteria for personal health
checks that may be used to inform policy, the experi-
ences and perspective of all stakeholders should be con-
sidered as they may identify different values, ethical
dilemmas and practical barriers. Here we describe the
results of an interview-study of providers’ views on cri-
teria for good health checks. The perspective of health
check providers is of particular importance, because they
– within the limits of the law – determine which checks
are offered to whom in which way. First, if their perspec-
tive differs in important aspects from criteria, a non-
binding guideline may not suffice to improve the offer of
health checks. In fact, this is one of the reasons that the
aforementioned guideline of the Royal Dutch Medical
Association has been withdrawn: its effects were limited
because commercial providers of health checks did not
endorse it. [20] Second, providers are well positioned to
identify practical and ethical barriers in the implementa-
tion of ethical (criteria for) personal health checks. Some
of these may be removed.
In our interview-study with a wide range of providers,
we investigate what they consider criteria for ‘good’
health checks, whether they differentiate between cri-
teria for population screening and for personal health
checks, and we explore what role the aforementioned
criteria play in their practices.
Although providers have been involved in the develop-
ment of earlier criteria and guidelines [1, 13–15] and
have been interviewed about the desirability of particular
health checks in evaluation studies (e.g. [21, 22]), this is
– as far as we know – the first paper on the views of a
wide range of providers on general criteria for good
health checks (i.e.preventive or presymptomatic tests)
would be.
Of course, the criteria as formulated by providers
should not be taken as a final say, but used as input in
the ethical and policy debates over the right criteria. We




Twenty semi-structured interviews were conducted in
Dutch by Yrrah Stol (YS) in 2015 lasting 45–90 min.
With one exception, interviews were conducted at the
workplace of providers of health checks. Respondents
were asked to share their opinions freely and were as-
sured their answers would be anonymized. They all con-
sented to publication of findings. We asked them what
kind of check(s) they offer, their reasons for doing so,
and the benefits and potential drawbacks of these
checks. Subsequently they were asked an example of a
good personal health check, and what general criteria
for ‘good’ personal health checks would be. Similar ques-
tions were raised about ‘bad’ checks. Although we did
define health checks (‘checks on (risk factors for) disease
in people without specific medical indication’) we delib-
erately left open the question of what aspects of a ‘good’
or ‘bad’ check would be so that respondents were free to
mention test- and disease characteristics, but also fea-
tures of the provider, offer or context in which this offer
is made. Providers were also asked what they would con-
sider desirable policy concerning personal health checks.
Finally, we asked them whether their current practice
leaves room for improvement and how this may be
achieved. (Additional file 1) Before the start of the inter-
view, we told providers interviews would be used to in-
form an ethical framework for health checks that we are
developing to guide policy.
Participants
Interviews were conducted with direct providers as well
as managers of health check businesses: GPs (GP), phys-
iotherapists (PHY), health and safety officers (HSO),
pharmacists (PHA), population screening program offi-
cers (PSPO), screening by GP program officers (GPSPO),
independent treatment centres providing insured
(ITC-I) and uninsured (ITC-U) care, and Internet based
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companies (IC). (Additional file 2) They offered the follow-
ing health checks to the Dutch public: tests for cardiovas-
cular risk factors (sugar, blood pressure, cholesterol, BMI,
questionnaire on lifestyle), tests for cancer (PSA test, rec-
tal examination, mammography, cervical smear, stool test),
total body scans, and other blood tests (e.g. sexually trans-
mittable diseases (STD) tests, thyroid- kidney- and liver
function, vitamin-, mineral- and hormone tests, hepatitis
B&C tests).
We chose the range of providers based on our own
knowledge of the field. We included both providers of
all commonly performed checks (such as cholesterol
tests and governmental screenings) and providers of the
checks that are currently widely discussed in the
Netherlands (such as the total body scan and PSA tests).
Although they themselves do not provide personal
health checks, governmental screening officers were
approached because of their knowledge of the field. Our
aim was to include a sample of health check providers
that was as diverse as possible because different pro-
viders may stress different criteria. We interviewed med-
ical specialists in commercial and regular care,5 directors
and key players of big organisations as well as health
check providers in one-man companies, providers that
conduct health checks face to face as well as those who
supply via Internet. Sex and age of providers were no se-
lection criteria, as we did not consider it likely that these
characteristics would influence criteria. We identified in-
dividual candidates from our own network, through an
internet-search, via other experts on health checks in the
Netherlands and via snowballing. Providers were
approached by e-mail and then called by telephone to ask
whether they were interested to be interviewed. Of the
twenty-eight providers that we approached, twenty agreed
to an interview. We managed to arrange interviews with
major players in the field. However, we did not succeed in
including ‘small’ commercial providers without a (para)-
medical background: five of the eight providers that de-
clined were small commercial providers.
Saturation as regards to criteria for health checks was
reached long before the last interview.
Analysis
Interviews were recorded and transcribed verbatim.
They were coded using NVIVO 10.2.2 for Mac focusing
on characteristics of ‘good’ and ‘bad’ tests. An initial list
of bottom-up derived codes reflecting characteristics of
good and bad health checks and a range of other themes
(such as information, autonomy and the organization of
healthcare) was composed and discussed between YS
and Eva Asscher (EA) after 10 interviews. Additional
bottom-up codes were added during the analysis, staying
close to the content of the answers of respondents. Simi-
lar codes were merged. Two interviews were double-
coded by EA to ensure agreement about the codes, there
was agreement about the codes used. Analysis of codes
to results was done by YS in close consultation with EA
and Maartje Schermer (MS). Quotes were translated
from Dutch to English by YS.
As we concentrate on criteria for good health
checks in this paper, we report on provider’s reasons
for offering checks and their opinion on policy only
when relevant.
Results
Criteria for good personal health checks
Providers consider characteristics of the test itself, the
disease tested on and how health checks are performed
(the offer, provider and target population) part of what
makes a test good or bad.
We divided the criteria mentioned by providers in
three categories: Minimal criteria were (almost) unani-
mously mentioned by interviewed providers. These cri-
teria are moreover decisive in the distinction between
good and bad test: respondents described tests that do
not meet minimal criteria ‘bad’. E.g. a good test is reli-
able and valid, a bad test unreliable and invalid. Aspir-
ational criteria were mentioned by only part of the
providers. Checks that do not meet these criteria are not
necessarily considered ‘bad’, respondents merely think
that health check offers could be improved by complying
with these criteria. Contested criteria are aspirational
criteria where providers (heavily) disagree about.
We discuss all types of criteria and illustrate them with
quotes. The selection of quotes is based on their concise-
ness and appeal, and represent different providers. For rea-
sons of anonymity, we may leave aside whether providers
refer to their own health checks or the offer of others.
Criteria are summarized in Table 1.
Minimal criteria
1. Health check results must provide clear opportunities
for health improvement
To benefit users, nearly all providers state that a good
check must provide clear opportunities for health
improvement:
First and foremost, you should perform a test only in
those cases in which you can act on the results, the
condition should be treatable, it should be possible to
relieve symptoms [once they present themselves YS].
But preferably that you can detect it in such an early
stage that it can be prevented. That, for me, is the
main characteristic of a good test (HSO).
In the end, it has to be a treatable condition. (GP).
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(Risk factors for) disease must be treatable either
through preventive lifestyle changes, medical interven-
tion or changes in the environment. Moreover, providers
almost unanimously characterise health checks that
(also) test for diseases for which no treatment or preven-
tion is available as ‘bad’; these would harm users by
causing concern and a loss of experienced health:
You have to be able to act on it. You need to give a
therapy option. If you don’t have one (…) one
becomes worried and therefore it is not a good test
(ITC-U).
The total body scan6 is an often-mentioned example
of a test that may reveal untreatable conditions.
2. The health check must be reliable and valid
The second criterion providers almost unanimously
mention is that personal health checks must be reliable
and valid tests. Providers stress both the importance of
analytical and clinical validity: If the conditions remain
the same, results should be consistent, and personal
health checks should accurately predict the presence or
absence of the (risk factor for) disease. This is operation-
alized in a high sensitivity and specificity and good
positive and negative predictive value for the (risk factor
for) disease:
A reliable, valid test, that is [criterion] one (PHA).
The higher the sensitivity, the higher the specificity,
the better it is (ITC-U).
It is remarkable how many providers stress the im-
portance of combining tests for risk factors: this
would give a better indication of disease developing
in the future. According to providers, risk factors for
cardiovascular disease (CVD) should be considered in
combination, and Prostate Specific Antigen (PSA)
should be checked in combination with a rectal
examination:
Cholesterol alone is not enough. For only a part of a
cardiovascular risk profile, but that’s it. (…) If you
want to compose a cardiovascular risk profile.. Then I
would say yes that makes sense (HSO).
80% of the men referred (…) [to this clinic] with an
increased PSA did not get a rectal examination. The
first step in diagnosing prostate cancer.. 80% did not
get a rectal examination (ITC-I).
Checks that do not meet the reliability and validity cri-
terion are characterized as ‘bad’ by nearly all providers
because they may harm individuals. People should not
be falsely reassured and false positive test results should
be kept to a minimum because they may cause
medicalization, unnecessary worries, over-treatment and
unnecessary burdens on the health care system:
R: Sensitivity and specificity are truly essential. (…) I
think that there are many health checks in which the
tests are such that they result in a substantial amount
of false positives. I think yes, many worried people
will be referred with all the associated consequences.
I: What consequences do you have in mind? R:
overdiagnosis to start with, more referrals to health
care, perhaps burdensome examinations, a trajectory
full of uncertainty (PSPO).
A test on total-cholesterol is an often-mentioned
example:
It tells you nothing, total cholesterol. It can be five or
four, you think great, but it could be that the [LDL/
HDL] relation is skewed, so these people are left none
the wiser: you’re okay. I consider that even worse
(ITC-U).
Table 1 Minimal, aspirational and contested criteria for good
personal health checks as formulated by interviewed providers
Minimal criteria Treatability of (risk factors for) disease: Health
check results must provide clear opportunities
for health improvement
Clinical validity: Health check results must be
valid and reliable indicators for (risk factors for)
disease
Informed consent: Participation must be
voluntary and based on reliable information
Health checks should provide more benefits
than harms
In case of population screenings: cost-
effectiveness
Aspirational criteria Follow-up care should be provided, including
objective explanation of test-results and
facilitation in the realization of health benefits
Providers should be skilled and experienced
professionals that put the benefit of (potential)
users first
Providers should take time and attention
Contested criteria People should be free to test on any (risk
factor for) disease, provided they are well-
informed
Assessment before the test: Health checks
should only be performed in people at high
risk for disease
Follow up care of privately funded tests
should not drain on collective resources
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3. Participation must be voluntary and based on
reliable information
Providers consider it problematic when people feel
pressured or are actually pressured to test due to the
conflict with self-determination:
Some people want to know, and others do not at all.
People should be free in this decision. One certainly
should have the opportunity to say ‘No, I prefer not to
know’ (GPSPO).
Good information is almost unanimously mentioned
as characteristic of a good check. Potential users should
be informed about the advantages, disadvantages and
limitations of the check beforehand to ensure informed
consent (or dissent):
I consider that one of the most important criteria for
good health checks, and that is that you provide
people with sufficient and reliable information in
advance (ITC-U).
Good information is very important, according to me.
And good information may also result in a decision
not to test (HSO).
Some providers also explicitly state they consider a
check ‘bad’ when informed consent is lacking.
4. Health checks should provide more benefits than
harms for the individual
Some providers explicitly mention this overarching
criterion:
The balance between pros and cons, that is crucial to
me (PSPO).
There are two sides to each check. (…) You aim
for something that people.. which is quite
specific .. where people can act upon, where they
can do something about. (...) But the downside,
the risk is always that it leads to medicalization
(HSO).
Many state that health checks should not cause dir-
ect harm and only minimal burden. In fact, they al-
most unanimously state that the government should
forbid the offer of directly harmful tests (eg using X-
rays)7 or should ensure these tests meet high quality
standards:
People need to be protected against unsound
or really dangerous tests. So it should be possible
to ban unsound or dangerous health checks
(ITC-U).
Often this criterion refers not only to the test itself,
but also to the whole trajectory of testing and treatment.
Many providers express worries concerning over-
treatment of prostate cancer which may cause impo-
tence and incontinence while the detected cancer may
not have resulted in health problems:
It results in a nasty urological treatment, that could
be useful for some, but is not for the majority (GP).
To assure health benefits and to avoid harm, the pres-
ence of disease should have implications for (future)
wellbeing.
In case of governmental screening programs, inter-
viewed providers formulate an additional minimal
criterion:
5. Health checks should be cost-effective
Providers differentiate between personal health checks
and governmental screening programs when it comes to
the cost-effectiveness of the check. Governmental
screening programs should be cost-effective: the costs of
the screening program should be in proportion with the
expected gain in health.
Costs certainly play a role in governmental screening
programs. The tests should be affordable. (PSPO).
An individual check up is very different to population
screening in this regard. For the moment you’d say
‘everybody between age fifty and seventy gets a [free
YS] total body scan’, you’ll make costs of formidable
size (ITC-U).
Aspirational criteria
1. Follow-up care should be provided, including
objective explanation of test-results, referral to
specialized care and assistance with the realization
of health benefits
Many providers stress that results are meaningless un-
less properly interpreted and put in perspective. Explan-
ation of results may also prevent harm resulting from
overtreatment and unnecessary worries. An often-
mentioned example in this regard is the PSA test. Pro-
viders should take sufficient time to explain that prostate
cancer need not always to be treated but may in some
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instances better be monitored with regular rectal exami-
nations, PSA tests, biopts and/or MRI’s.
Interviewed providers also stress that users need to be
referred to specialized care if tests results warrant so.
Finally, to realize health benefits after the test, users
should be informed about, advised on, and – according
to some providers – if necessary assisted with the
realization of treatments and/or lifestyle adjustments:
If a doctor says “go exercise more”, that is one thing,
but to actually do it is something altogether different.
And I often think that many people really need a big
stick and need some advice. It is often easier said than
done is my experience. (Physiotherapist).
2. Providers should be skilled and experienced
professionals that put the benefit of (potential)
users first
Many providers think that health checks should pref-
erably be offered and performed by skilled and experi-
enced health care professionals because they have the
capabilities to properly inform (potential) users about
the benefits and harms of a test, to interpret test results
and to explain their relevance to users:
Quality has to do with the quality of the test, and with
the quality of the doctor. A test may have a high sensi-
tivity, high specificity, but if the doctor is not able to in-
terpret the results … I always stress, I find it very
important that people realize that early diagnosis is a
profession. In everybody I investigate I’ll find something.
Of course, because I’m looking at a body and no one
body is built the same, so you’ll always find variations on
the norm. And it’s very important to get to know those
variations on the norm so you know when to act and
when not to do so. (ITC-U).
Furthermore, some providers state that the interests
of (potential) users should come first in the provision of
health checks. They warn for (financial) incentives to
test or treat in commercial providers, but also in regular
care:
When it comes to prostate cancer, the biggest crime is
the robots that those hospital directors have put
down. To their urologists, they say ‘I’ll buy a robot for
you if you remove 200 prostates’. That’s horrible. (...)
Don’t do a [PSA] test at a urologists under pressure to
operate (ITC-I).
3. Providers should take time and attention
In order to properly inform, advise and assist (poten-
tial) users before and after the test, providers emphasise
the importance of time and empathy:
You need to take the time to explain. (…) Time, time..
That is of crucial importance to patients (ITC-I).
Contested criteria
1. People should be free to test on any (risk factor for)
disease, provided they are well-informed
A large number of the providers, including all com-
mercial ones, state that testing or not should ideally be
an individual choice. With the exception of directly
harmful health checks, people should be able to do a
personal health check on any (risk factor for) disease,
provided they are well-informed:
Health is our most precious possession, and every
individual, every citizen has the right to make
decisions about their own health. And thus to have it
examined when he or she wants to. That’s just a basic
right. (ITC-U).
2. Health checks should be performed in people likely to
benefit most from the check
In contrast, other providers state that people should
not be free to participate in whatever health check,
but that it would be best if health checks were
performed in people likely to benefit most. To
optimize the benefit-harm ratio of health checks,
health checks should only be performed in people at
high risk for disease. This will enhance the positive
predictive value of the test, which depends on the
prevalence of disease. Checks moreover should only
be performed in those likely to implement health ad-
vice. An often-mentioned example is that checking
for CVD is only useful when people are willing and
capable to implement lifestyle changes that are re-
quired to lower risk:
Preventive research [including health checks YS] also
has to do with what people are willing to do with the
results (IC).
Only in people who are willing to take the
consequences, testing [for CVD risk factors] is useful
(ITC-U).
Some health check providers therefore advice to assess
risk factors and likelihood of implementing health advice
before the test and to perform health checks only in
those people most likely to benefit from the test. They
warn of commercial providers, but also of patient groups
and medical specialists with a particular focus on the
disease tested for, who may be:
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very focused to detect so to speak the last patient with
cancer left. Very driven to do so. Not surprising of
course, for they are confronted with the consequences
of cancer for people in their practice. (PSPO).
The downside of this focus would be that they may
offer tests to people at low risk for disease, which may
result in many false positives.
Benefits other than health, such as reassurance, may also
be taken into consideration. According to the providers
who state that health checks should only be performed in
people who are likely to benefit most, people at low risk
who are extremely worried should still be able to test, be-
cause reassuring them may improve their wellbeing al-
though it’s unlikely health benefits will result:
If somebody is worried sick, and thinks ‘I’ve got it’
[lung cancer], than yes, that person should be given
the possibility to check (PSPO).
3. Follow up care of privately funded tests should not
drain collective resources
To ensure affordable health care, some providers cau-
tion about privately provided tests that may cause
follow-up in regular health care possibly draining col-
lective resources. The total body scan is often mentioned
as an example:
It [a total body scan] produces a lot of unnecessary
additional medical consumption. (…) Obstruction,
unnecessary [follow up] research, that is a waste (...)
Not just of money but of time. Time of the people
who have to do those [follow up] tests, time in the
hospital for things that are not useful, which makes
other people having to wait longer (GP).
Criteria in practice
So far the focus has been on criteria for good health
checks according to providers. This final section is de-
voted to the role of these criteria in the current offers of
health checks. Which checks do – according to pro-
viders – meet the criteria for good health checks, and
which do not? Do providers themselves comply with cri-
teria? Is it feasible to fulfil these criteria according to
providers?
Good’ and ‘bad’ health checks
During the interviews many providers had serious difficul-
ties mentioning a health check that they considered to be
‘good’. Many of them mention other forms of prevention
instead, such as vaccinations, easily accessible preventive
activities such as sports and smoking cessation programs,
and tackling the obesogenic environment:
Uhm, I’m in doubt.. I can not just name one, because
you have indeed the false positives and treatment.. it
isn’t always easy.. You’re talking about tests, not about
preventive vaccinations, those kind of things, you’re
really asking for a test (PSPO).
When asked for an example of a ‘bad’ check however,
providers readily named tests, often the total body scan
and tests on total cholesterol.
Why providers don’t comply with the formulated criteria
Providers reflected on their own offer of tests to empha-
sise what they think is important in a test, and were
asked whether their current practice leaves room for im-
provement and how this could be achieved. Providers
readily admitted they didn’t consistently meet their own
criteria for good checks. Some of them offer checks that
may detect untreatable disease and tests with a low pre-
dictive value. They do not always sufficiently inform po-
tential users, the follow up of some of checks drains on
collective resources, and follow up care is not always
provided. Especially help with lifestyle changes following
checks on CVD risks is rare.
Several reasons were mentioned for this gap between
theory and practice. First, many providers struggle with
the tension between the importance they attach to reli-
able, valid health checks that improve health, and their be-
lief that potential users – provided they are well-informed
– should be free to choose any personal health check they
want, including tests that are unreliable, invalid and are
unlikely to improve health, for example because (poten-
tial) users do not belong to the target group:
I am a strong proponent of self-determination. If I
want to have my creatinine checked, I believe this
should be possible. And I also believe that if I want to
have my PSA checked – which is such a discussion –
I believe I should be able to have my PSA checked.
And a GP may think I shouldn’t, but then I think this
GP needs to explain to me why I shouldn’t. But even
then I believe I should be able to request that [a PSA
check]. If, of course, I fit into a specific group [popula-
tion]. If I’d be 30, well.. No anyway, then it should still
be possible (ITC-U).
Second, especially medical specialists express a strong
desire to prevent serious illness and death from disease
while (as yet) no test with good predictive value is
available:
Look, a PSA test is obviously not a good test and
should also not be used for screening. That’s not a
good test, especially the specificity is much, much,
much too low. But there is nothing better. (...) That is
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a real miserable death, prostate cancer is the most
miserable death from cancer that you can imagine.
You’ll get metastases in your bones, it will take three
years, it is terribly painful, it’s an enormous decline
because it is such a slow-growing killer. So look, and
that’s exactly what I want to prevent, that misery (ITC-I).
Third, many providers, especially GPs, suffer from a
lack of time. In practice they cannot properly inform, ad-
vise and assist (potential) users before and after the test:
I find it difficult in cases in which a patient says: I
want my PSA checked, that just takes a moment isn’t
it doctor? That happened a few times, to then explain
as good as possible how it is (GP).
Fourth, although all respondents would like to provide
good care, providers other than the government and
GPs make (part of ) their living selling health checks, so
they have an interest that may conflict with offering reli-
able, valid checks that provide health benefits:
We are a commercial company as well... yeah. So I
mean.. would you in such a situation also think “well,
should I do this [offer this test] or not”? Yes that can
be difficult, to make honest weightings, therein. Yes,
I’m very honest about that (HSO).
A similar conflict is reported concerning the provision
of objective and full information to potential users:
Really, I would.. I think you should give objective
information. (...) Look the point is, and that has to do
with market forces in health care, you’ll always .. the
biggest .. uhm... challenge is in recruitment versus
information. Recruitment meaning how do you
recruit your clients, and how do you give the right
information. (...) How do you do a.. recruitment in
which you do alert people to potential risks or
disadvantages (ITC-U).
Informed consent may be difficult to establish
According to interviewed providers, informed consent is
a minimal criterion. As just described, sometimes pro-
viders fail to supply potential users with sufficient infor-
mation. A majority of the interviewed providers however
questions whether true informed consent is feasible at
all. Even if potential users would be provided with ob-
jective, reliable, valid, accessible and understandable in-
formation; this would not necessarily enable them to
make informed assessments concerning benefits and
harms of tests. This is because many people, according
to providers, have difficulties with making ‘rational’ deci-
sions in the context of health:
What people understand and what people want to
understand, you can explain something very well, but
sometimes people just want to read something else, so
(ITC-U).
The context in which a check is offered is said to have
a big influence on decisions (not) to test. When a test is
free, easily accessible, if ‘everybody’ participates, and
when potential users trust the provider, people would
hardly consider information at all:
Yes, the more accessible it is, if it becomes
common practice, the less people tend to think
about what the consequences might be if you do
that [testing] (PHA).
According to providers, health related choices are
influenced by fear of death (rather safe than sorry).
Faced with the possibility of serious disease that can
be treated at an early stage, people are willing to
accept unnecessary worry and even damage to health
that may result from overdiagnosis and overtreatment.
Many providers thus explain choices to test for pros-
tate cancer.
People always tend to believe the worst case
scenario. (…) A certain fear to have something, a
fear of illness (…) [They take the PSA test] we’ll
treat them and they will be glad we do. In the
meantime they’re confronted with incontinence,
impotence, that sort of thing. And surprisingly
enough, they take it for granted. (...) They’ll reason
I have prostate cancer and I’ve been treated .. so I
escaped death (GP).
Interestingly, the very same providers also make
comments in which nothing echoes the aforemen-
tioned nuances to the view of man as rational deci-
sion maker:
If they want to spent their money on that [total body
scan YS] instead of on a vacation. Well, why not, that
is their choice (GP).
People should just be smart enough to decide whether
or not they participate in checks, ok? (ITC-U).
As long as information is provided, choices would
simply reflect what people want. Providers make these
comments to justify their own practice, but are also
in relation to health checks offered by other
providers.
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Discussion
Providers’ criteria are demanding
When we compare the criteria formulated by the pro-
viders with existing criteria for personal health checks
and population screening, five points stand out. First,
the criteria as formulated by the interviewed providers
resemble the criteria for responsible population screen-
ing closely. Analytic validity, clinical validity, clinical use-
fulness, benefits outweighing harms and informed
consent are all considered minimum criteria. Providers
also state that governmental screening should be cost-
effective. Providers, thus, agree with ethicists that the
Wilson and Jungner criteria are also applicable to per-
sonal health checks. [2, 4–6]
In the regulatory context of personal health checks,
the opinions of providers however, give a new perspec-
tive. Their criteria are actually more demanding than cri-
teria formulated for personal health checks thus far.
Providers consider health benefits and clinical validity
minimal criteria for personal health check, as for popu-
lation screening. In contrast, clinical utility is mentioned
in none of the existing criteria for personal health checks
[1, 13–15] and clinical validity in only one. [1]
Third, the ideas about follow up care of interviewed
providers are more demanding than criteria formulated
for responsible population screening and criteria for per-
sonal health checks. In population screening people are
informed about the meaning of results and referred to
specialized care, criteria for personal health checks in-
clude ‘advice to clients on strategies the client can follow
to reduce any further risk of acquiring a condition(s) or
its negative consequences.’ ([13], see also [14]) Several
interviewed providers however advise to help users in
realizing the actions necessary to reduce risk.
Fourth, it is remarkable that interviewed providers make
almost no remarks about privacy and storage of data. Cri-
teria for responsible governmental screening state that
offer and performance should be in accordance with pa-
tient and consumer rights. Criteria for personal health
checks explicitly mention the handling of data. [1, 13–15]
We think the fact that interviewed providers seem to take
patient- and consumer rights as given could best explain
this apparent omission (Additional file 3).
Last but not least, the interviewed providers have spe-
cific concerns about informed consent. Although they
consider this a minimal criterion, they question its feasi-
bility in practice. According to providers, people would
be more influenced by context and emotions than by in-
formation in their decisions to test. This is a cause for
concern, considering the importance placed on informed
consent in the existing criteria for personal health check.
In these criteria, informed consent is not only consid-
ered as a criterion in itself but also as a condition to en-
sure that individual benefits outweigh harms because
informed individuals would be able to determine
whether that is the case. [1, 13–15] According to inter-
viewed providers this is, thus, not realistic. To ensure
health checks provide more benefits than harms, they
instead mention an individual assessment before the test,
help with the implementation of health advice after the
test, and providers being skilled and experienced profes-
sionals who put the benefit of (potential) users first and
take time and attention in their provision of care. Al-
though some proposals for the ethical evaluation of per-
sonal health checks mention assessment of risk factors
[7, 9] or qualified providers [8, 9], their emphasis is on
informed consent.
Providers don’t meet criteria: Lessons
Interviewed providers have difficulties mentioning per-
sonal health checks that meet their criteria. Moreover,
they do not consistently meet the formulated minimal
and aspirational criteria in their own practice. Respon-
dents name several reasons for this gap between theory
and practice. We discuss their implications for the us-
ability of criteria for personal health checks.
First, primarily the commercial providers struggle with
the tension between the importance of reliable, valid
checks that improve health and their belief that potential
users should be free to choose any test they want, in-
cluding unreliable, invalid tests that do not provide op-
portunities for health improvement, provided they are
well-informed. This contested criterion (nr 1) is hard to
reconcile with the minimal criteria, which these pro-
viders, thus, often fail to meet. There are commercial
motives at play, but non-commercial providers also state
that people at low risk that are extremely worried should
be able to test, regardless the fact that the validity of test
results will be negatively influenced and it is unlikely
that health benefits will result. (see contested criterion
2) This apparent dilemma between avoidance of harm
and respect for autonomy emphasises that a list of cri-
teria may contain value conflicts that are not easily
resolved.
Second, providers are sometimes faced with the di-
lemma that they want to prevent harm from disease, but
have no options except health checks with poor predict-
ive value, which may result in harm due to over-
treatment and unnecessary worries. On a population
level, it may not be easy to identify when health checks
no longer provide more benefits than harms. On the
level of an individual user or patient, providers – like in-
dividuals themselves – reason it is better to be safe than
sorry.
These dilemma’s point out that in developing ethical
criteria for offering health checks potential conflicts be-
tween criteria and underlying values should be expli-
cated and addressed.
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Other reasons why providers do not meet criteria
point to components in the organisation of health care
that may conflict with an ethical provision of health
checks: Especially GPs report that they lack time to
properly inform, advise and assist (potential) users be-
fore and after the test. This has been reported before in
studies on preventive care in general practice. [23] They
express moral frustration about this situation because
they want to provide good care.
Some (semi) commercial providers have an interest
that sometimes conflicts with offering reliable, valid
checks that provide health benefits and giving objective
and full information to potential users. Commercial pro-
viders are faced with the question why their practice
should be moral if they could make money instead. The
question ‘why be moral?’ may be even more central in
the practice of the ‘small’ commercial providers without
a (para) medical background which rejected our request
for an interview by stating that this ‘would be at the ex-
pense of customers who pay € 225 per hour’.
These dilemmas point out that in thinking about the
ethics of offering health checks; we should take the lar-
ger context into account. It is important to realize the
conditions that would facilitate providers to meet the
criteria. Other actors, like the government or insurance
companies, need to take responsibility here as well.
When it comes to the usability of general criteria for
personal health checks there is of course also the general
problem of the application of criteria. As mentioned in
the introduction, the criteria for population screening
may be relatively uncontested, but whether or not spe-
cific population screening programs meet these criteria
is subject of debate. [9] Agreement about general criteria
for personal health checks is thus only a first step to-
wards the ethical evaluation of specific checks. When is
a test ‘reliable’ and ‘valid’ enough? General criteria must
be interpreted for specific tests, and it may well be that
different providers will interpret criteria differently or
that there will be dissensus when it comes to applying
general criteria for specific tests. To our mind, standards
should be at least as demanding as those of population
screening.
Contested criteria: Ethical evaluation
The criteria as formulated by providers should not be
taken as a final say, but used as input in the ethical and
policy debates over the right criteria. Their minimal and
aspirational criteria are in line with what most ethicists
consider to be good (personal) health check offers. [2, 4–6]
This is different however, when it comes to contested cri-
teria. In this section we provide an ethical evaluation of
these contested criteria and explore their relevance for an
overarching ethical framework for responsible offer and
use of personal health checks.
Respecting autonomous choice
The idea that people should be free to participate in un-
reliable, invalid checks on (risk-factors for) disease that
cannot be treated provided that they are well-informed
may be seen as an attempt to prevent harm from checks
while respecting autonomous choice. Autonomy is a key
value in medical ethics. [24] We briefly discuss how we
understand autonomous choices in the context of health
checks and evaluate this criterion on this basis.
An autonomous choice is a choice made in freedom, a
choice that is in line with somebody’s values, with his or
her perception of the good life, a choice that ideally is
based on reliable information. [2, 24] Interestingly, many
providers – commercial and non-commercial – think
people would be more influenced by context and emo-
tions than by information in their decisions to test. In-
deed people may not be capable of using the
information provided during informed consent proce-
dures in decisions to test because they lack the health
literacy to do so [25, 26] or because emotions or heuris-
tics override rational considerations. [27].8
If providing information to potential users does not
necessarily lead to autonomous choices (not) to partici-
pate in health checks, how to evaluate these choices?
This should depend on whether that choice is conduct-
ive to this individuals’ own perception of a good life. [2]
Most people value health more than anything else. [28]
In addition, a choice for a test should be in line with
what the individual wants or expects from the check.
[29] Many people expect tests to have a good predictive
value, to offer opportunities for health improvement and
not to inflict any harm [30] and participate for reasons
of health. (e.g. [31]).
From this we may conclude that offering tests with a
low predictive value that do not provide health benefits
is not likely to be conductive to the autonomy of (poten-
tial) users. This is because most people value health, ex-
pect health check to provide certainty about the
presence or absence of disease and test to improve
health. [29–31] Moreover, providing information about
test- and disease characteristics that are contrary to what
people expect will probably not suffice to prevent harm
because decisions (not) to test are more often made on
the basis of emotions and heuristics than information.
[25–27] The idea that people should be free to partici-
pate in whatever check, provided that they are well-
informed is thus not likely to result in respect for au-
tonomous choice while preventing harm from checks.
This is different when potential users would be ‘in-
formed’ in individual assessments, as some providers
suggest in the context of contested criterion 2. In such
assessments, risk factors and likelihood of health advice
being implemented would be discussed and the individ-
ual needs of potential users would be deliberated upon.
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[32] This way, unrealistic expectations may be corrected
[29] and individual benefits and harms could be deter-
mined in the context of individual needs. Such individ-
ual assessments – perhaps best comparable to
counselling in clinical genetics – would require personal
contact and thus take time and attention from providers.
They may also require offering less comprehensive tests.
For example, it does not seem realistic to discuss all
relevant benefits and harms of a total body scan or
broad genome-wide testing. [33]
In case of health checks with a low predictive value or
checks that do not provide opportunities for health im-
provement, we thus suggest performing individual as-
sessments as ‘alternative’ informed consent procedures.
This way, it is assured that participating is in line with
individual’s values and expectations and provides more
benefits than harms.
This analysis of autonomous choice and the limitations
of informed consent has implications beyond an ethical
provision of health checks. In general we think it is im-
portant to design informed consent procedures such that
they truly function as means to respect the autonomy of
(potential) users. [24]
Taking the context into account
The suggestion of some providers to perform in particu-
lar cardiovascular health checks only in people who are
willing and capable to implement any lifestyle advice
could, like a recent, very similar advice from the US Pre-
ventive Service Task Force [34], be criticized as ‘with-
holding potential benefit from the population subgroups
whose socioeconomic burdens and comorbidities place
them in greatest need of help’. [35]. After all, the low
SES groups who are, according to interviewed providers,
not likely to implement health advice have on average a
bigger risk on cardiovascular disease. [36, 37]
However, a different picture arises if we would evalu-
ate this suggestion from a ethical perspective in which
the context is taken into account. We think that a true
ethical provision of health checks requires weighing ben-
efits and harms of health checks against other measures
targeting (risk factors for) disease. Let us weigh the ben-
efits and harms of cardiovascular health checks up to
benefits and harms of other measures targeting (risk fac-
tors for) CVD: asking people to change their lifestyle if
they’re not capable to, is not likely to improve their
health but may cause worries and feelings of guilt. [3]
Low SES groups indeed deserve care, but may need dif-
ferent care than the provision of cardiovascular health
checks. [31] It would be more fair and effective to help
those people maintaining a healthy lifestyle by changing
the obesogenic environment they live in. [38–40] Think-
ing about the ethics of health checks may thus also re-
sult in an advice to implement other measures than
health checks, for certain subgroups or in general. To
change the obesogenic environment other actors than
providers need to be addressed, such as governments
and industry. [3]
Limitations of the study
We have chosen a qualitative approach because we
are the first to question providers on an ethical
provision of health checks and the openness of a
qualitative method allows the uncovering of unex-
pected views. The aim was an in-depth understanding
of what providers consider criteria for good personal
health checks and potential barriers in the implemen-
tation of these.
Although we interviewed a very divers sample of pro-
viders, saturation as regards to criteria was reached long
before the last interview: they formulated very similar
and ‘demanding’ general criteria. We did not expect this
to happen. Despite differences in education(al) level,
profession, work field and interest, providers – appar-
ently – have very similar ideas when it comes to the eth-
ics of health checks. Although we cannot exclude the
possibility of a social acceptability bias in their answers
– respondents were aware that they were interviewed by
an ethicist and perhaps did not want to come across as
thoughtless – however we do not consider this a likely
scenario. The atmosphere during most9 interviews was
perceived by YS and described by respondents as sur-
prisingly open and relaxed.
In addition, providers were aware that their answers
would be employed in the development of an ethical
framework for personal health checks. Strategically pro-
viders had every reason to be somewhat less demanding
while showing goodwill to make some adjustments in
their offers. Such a position after all would minimize the
chances of (governmental) involvement in their prac-
tices. That being said, our results may suffer from a sam-
pling bias: ‘Small’ commercial providers without a (para)
medical background who declined our interview re-
quests would perhaps have formulated less ‘demanding’
criteria. And the two providers of governmental screen-
ing programs came up with criteria very similar to cri-
teria for responsible governmental screening, as was
perhaps to be expected.
To draw conclusions on how many providers value
which criteria for good health checks, the results of this
study would need to be quantified.
A potential shortcoming of this study is the relatively
short section on criteria in practice as these results are
the most interesting from an ethical point of view. The
reason why we do not have more material to present is
that we wanted providers to be as open and honest
about their practices as possible in an interview with an
ethicist, and figured they would be more at ease if we
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did not question them too directly and long about
whether and why they (do not) keep to criteria.
Conclusions
Providers are more demanding than existing ethical cri-
teria for personal health checks and state that personal
health checks should meet the following minimum cri-
teria: (Risk factors for) disease to which the check is di-
rected should be treatable; Tests must be reliable and
clinically valid; Participation must be informed and vol-
untary; Health checks should provide more benefits than
harms; Governmental screenings should be cost-
effective. Some providers also formulate aspirational cri-
teria: Follow-up care should be provided; Providers
should be skilled and experienced professionals that put
the benefit of (potential) users first; Providers should
take time and attention. Providers disagreed over the fol-
lowing contested criteria: People should be free to test
on any (risk factor for) disease; Health checks should
only be performed in people at high risk for disease that
are likely to implement health advice; Follow up care of
privately funded tests should not drain on collective
resources.
Providers do not always fulfil their own criteria.
Their reasons reveal conflicts within the set of criteria
for good checks, conflicts between criteria and other
ethical values, and point to components in the organ-
isation of health care that hinder an ethical provision
of personal health checks. Moreover, many inter-
viewed providers consider informed consent a criter-
ion that is hard to establish in practice. An individual
assessment in which risk factors, the likelihood of
health advice being implemented and the needs of
potential users would be discussed is an interesting
suggestion for an informed consent procedure that
truly functions as means to respect the autonomy of
(potential) users. [24]
The results of this study suggest that in thinking about
the ethics of health checks, drawing up a checklist of cri-
teria will not suffice. Potential conflicts between criteria
and their values should be explicated and preferably help
in the weighing of criteria should be provided. Moreover,
in the ethics of health checks it is important to take the
larger context into account. It is important to realize the
conditions that would facilitate providers to meet the
criteria. Actors, like the government or insurance com-
panies, need to take responsibility here as well and thus,
should be addressed. Moreover, an ethical framework for
health checks should enable weighing up benefits and
harms of health checks to other measures targeting
(riskfactors for) disease. An ethical evaluation of health
checks within this larger context may result in an advice
to implement or promote other measures than health
checks.
Endnotes
1The screening and any subsequent interventions
should lead to an improved health outcome among
people with a positive test result.
2The accuracy with which the test measures a specific
biomarker.
3The accuracy with which the test identifies a particu-
lar (risk factor for) disease.
4Note that many more guidelines for direct to con-
sumer (DTC) genetic tests exist. [41, 42] We however,
only discuss guidelines applicable to all sorts of personal
health checks.
5In the Netherlands, people need a referral from their
GP to be treated or examined by a medical specialist in
regular/insured care. In contrast, care by specialists in
commercial/uninsured care is accessible without GP re-
ferral. Specialized medical care may either be provided
in hospitals (regular care) or in independent treatment
centres (either insured or uninsured care).
6There is currently much public debate in the
Netherlands concerning the Total Bodyscan. Thus far,
performance is forbidden in the Netherlands. However,
it is offered and performed just outside Dutch borders.
This may have influenced how often providers refer to
this test during the interviews.
7The Netherlands has a special law on screening: the
Population Screening Act. As explained in the introduc-
tion it states that population screening must benefit par-
ticipants. It operationalizes this through a mandatory
permit for (expected) harmful screening: that uses ioniz-
ing radiation, aims to detect cancer or diseases for which
no treatment or prevention. Grounds to refuse the per-
mit are 1. The screening test is scientifically unsound; 2.
The screening is not conform the legal rules for medical
treatment; 3. The expected benefit of the screening does
not outweigh the risks for the participants. To determine
the risk-benefit ratio for participants, the Wilson and
Jungner criteria are used. (HCN 2008) During the time
of the interviews, the minister of health of the
Netherlands deliberated on possible adjustment of the
Population Screening Act.
8One may wonder why providers state that people
should be free to test provided they are well informed, if
they think people would be more influenced by context
and emotions than by information in their decisions to
test. As discussed the very same providers that question
informed consent also make rather indiscriminate state-
ments about self-determination: choices would simply
reflect what people want. As most providers came across
as genuinely committed to the well-being of the users of
their test, a mechanism called ‘cognitive dissonance’ may
be at play. [43] Cognitive dissonance refers to the psy-
chological stress that results from holding a belief that is
contradictory to ones actions. To reduce stress, people
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may either adapt their ideas or their actions. [43] To fit
their practice in which they perform unreliable, invalid
health checks that do not always provide opportunities
to improve health but may even harm health, providers
may simplify their conception of self-determination. An-
other or additional explanation as to why providers state
people should be free to test provided they are well in-
formed is that they may hold on to informed consent
procedures as if it were an ethical anchor. Informed con-
sent procedures as something intrinsically good would
then outweigh uncertain harms done by unreliable or in-
valid checks that do not provide opportunities for health
improvement. Although this is an understandable
thought given the attention within medical ethics to in-
formed consent [24], informed consent should be under-
stood as a means to respect the autonomy of (potential)
users, not an end in itself.
9With the exception of two interviewees who seemed
on their guard.
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